| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Fixed maturities available-for-sale, at fair value (amortized cost: $291.7 and $208.3) | $293.4M+42.6% | $205.7M+27.2% | $161.7M | — | — | — |
| Short-term investments, at fair value (amortized cost: $152.5 and $167.6) | $152.5M-9.0% | $167.6M-10.4% | $187.1M | — | — | — |
| Total investments | $445.9M+19.4% | $373.3M+7.0% | $348.8M-21.8% | $445.9M+596.7% | $64.0M+14.3% | $56.0M |
| Cash and cash equivalents | $218.3M+10.5% | $197.6M+39.1% | $142.1M-26.9% | $194.5M-74.9% | $775.6M+71.5% | $452.3M |
| Restricted cash | $31.8M-9.7% | $35.2M-33.6% | $53.0M+6.0% | $50.0M+16.0% | $43.1M+7.5% | $40.1M |
| Accounts receivable, net of allowance of $0.2 and $0.6 | $250.1M+49.8% | $167.0M+15.0% | $145.2M+35.4% | $107.2M+89.7% | $56.5M+52.3% | $37.1M |
| Reinsurance recoverable on paid and unpaid losses and loss adjustment expenses | $346.6M+21.5% | $285.3M+1.4% | $281.3M-1.7% | $286.3M+7.3% | $266.9M+99.0% | $134.1M |
| Prepaid reinsurance premiums | $353.7M+29.0% | $274.2M-18.3% | $335.6M+8.3% | $309.9M+33.8% | $231.6M+79.0% | $129.4M |
| Ceding commissions receivable | $98.7M+24.2% | $79.5M+7.7% | $73.8M+61.1% | $45.8M+10.1% | $41.6M+95.3% | $21.3M |
| Capitalized internal use software | $43.0M-10.6% | $48.1M-0.6% | $48.4M+24.7% | $38.8M+49.8% | $25.9M+76.2% | $14.7M |
| Intangible assets | $13.8M-18.8% | $17.0M-37.7% | $27.3M+1.5% | $26.9M-16.5% | $32.2M-5.0% | $33.9M |
| Other assets | $103.6M+56.5% | $66.2M-4.3% | $69.2M+8.8% | $63.6M+22.8% | $51.8M+307.9% | $12.7M |
| Total assets | $1.91B+23.5% | $1.54B+1.2% | $1.52B-2.8% | $1.57B-4.5% | $1.64B+67.7% | $979.4M |
| Losses and loss adjustment expense reserve | $420.4M+20.1% | $350.0M+8.5% | $322.5M+9.8% | $293.8M+12.7% | $260.8M+148.1% | $105.1M |
| Unearned premiums | $579.7M+26.6% | $457.9M+9.2% | $419.2M+22.8% | $341.3M+34.8% | $253.1M+68.4% | $150.3M |
| Reinsurance premiums payable | $304.4M+22.4% | $248.6M-4.4% | $260.1M+25.6% | $207.1M+29.9% | $159.4M+85.1% | $86.1M |
| Provision for commission | $36.3M+5.8% | $34.3M+38.9% | $24.7M+394.0% | $5.0M-59.3% | $12.3M-56.4% | $28.2M |
| Surplus note | $47.9M | $0 | — | — | — | — |
| Accrued expenses and other liabilities | $80.7M-7.7% | $87.4M-23.0% | $113.5M-11.5% | $128.2M+34.4% | $95.4M+120.8% | $43.2M |
| Total liabilities | $1.47B+24.7% | $1.18B+3.4% | $1.14B+16.9% | $975.4M+24.9% | $781.0M-6.4% | $834.1M |
| Common stock, $0.0001 par value; 80,000,000 shares authorized as of both December 31, 2025 and 2024; 25,699,704 and 24,866,803 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $0 | $0 | $0 | $0 | $0 | $0 |
| Additional paid-in capital | $1.65B+0.7% | $1.64B+1.5% | $1.62B+3.7% | $1.56B+4.7% | $1.49B+2515.6% | $56.9M |
| Accumulated other comprehensive income (loss) | $1.8M+166.7% | -$2.7M+6.9% | -$2.9M+58.6% | -$7.0M-900.0% | -$700K-800.0% | $100K |
| Accumulated deficit | -$1.22B+4.5% | -$1.27B-3.3% | -$1.23B-28.4% | -$961.1M-53.0% | -$628.0M-144.7% | -$256.6M |
| Total Hippo stockholders’ equity | $436.1M+20.4% | $362.1M-4.2% | $377.9M-35.9% | $589.9M-31.4% | $859.6M+530.7% | -$199.6M |
| Noncontrolling interest | $0-100.0% | $3.1M-54.4% | $6.8M+88.9% | $3.6M+71.4% | $2.1M+2000.0% | $100K |
| Total stockholders’ equity | $436.1M+19.4% | $365.2M-5.1% | $384.7M-35.2% | $593.5M-31.1% | $861.7M+531.9% | -$199.5M |
| Total liabilities and stockholders’ equity | $1.91B+23.5% | $1.54B+1.2% | $1.52B-2.8% | $1.57B-4.5% | $1.64B+67.7% | $979.4M |
| Common stock, shares outstanding (in shares) | 25.70T+3.3% | 24.87T | — | — | — | — |
| Common stock, shares issued (in shares) | 25.70T+3.3% | 24.87T | — | — | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.